Latest Operational Performance News

Whitehaven Coal delivered a robust finish to FY26, hitting top-end guidance for production and sales while improving safety and reducing costs.

Web Travel Group projects solid revenue and margin gains for 1H27 despite currency headwinds, backing its outlook with a substantial $90 million share buy-back.

Genesis Minerals delivered record FY26 gold production within guidance, boosted cash flow, accelerated key projects, and agreed to merge with Vault to create a top 20 global gold producer.

EVZ Limited closed FY26 with a net positive operating cash flow of $10.1 million and an $18.3 million cash balance, while maintaining a robust $80 million contract backlog and progressing several acquisition opportunities for FY27.

Elevra Lithium’s North American Lithium operation hit a new monthly spodumene concentrate production record in May 2026 while closing a US$298 million financing package to fund expansion and project development.

Clean TeQ Water has marked a milestone with its inaugural recurring revenue from ATA® technology and a 45% jump in quarterly customer receipts, underpinned by contract wins and project progress across global water and critical minerals markets.

Stanmore Resources bounced back from early-year weather disruptions with a 27% jump in ROM coal production in Q2 2026 and secured a refinancing deal that lowers debt costs and extends maturities, positioning the company for a robust second half.

Fletcher Building has confirmed the release of government grant funds to Golden Bay Cement, enabling the purchase of New Zealand Units that underpin the plant's operation through 2040 and safeguard over 600 jobs in Whangarei.

Iris Cairns Property Trust has cleared key regulatory hurdles and removed the minimum acceptance condition from its takeover bid for Reef Casino Trust, holding nearly 80% of units and urging unitholders to accept before the 14 August deadline.

Integrated Research (ASX: IRI) reported a 13-17% decline in pro forma revenue for FY26, weighed down by a softer renewals book and weaker new business in H2. Despite this, cash reserves rose 27%, underpinning ongoing investment in the company’s product-led growth strategy.

MaxiPARTS upgrades FY26 operating profit guidance to $14.2 million, driven by strong cost control and a $9 million inventory reduction, while bolstering its executive team with key appointments.

Genetic Signatures has completed a major restructure delivering $5 million in annual savings from FY2027 and secured a decade-long supply contract with Denmark’s Hvidovre Hospital, while posting $14.8 million revenue for FY2026 amid market pressures.